Related references
Note: Only part of the references are listed.Association Between Negative Results From Tests for HBV DNA and RNA and Durability of Response After Discontinuation of Nucles(t)ide Analogue Therapy
Rong Fan et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2020)
Use of HBsAg quantification in the natural history and treatment of chronic hepatitis B
Lung-Yi Mak et al.
HEPATOLOGY INTERNATIONAL (2020)
Safety, pharmacokinetics, and antiviral effects of ABI-H0731, a hepatitis B virus core inhibitor: a randomised, placebo-controlled phase 1 trial
Man-Fung Yuen et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2020)
New Biomarkers of Chronic Hepatitis B
Lung-Yi Mak et al.
GUT AND LIVER (2019)
Short term RNA interference therapy in chronic hepatitis B using JNJ-3989 brings majority of patients to HBsAg < 100 IU/ml threshold
Man-Fung Yuen et al.
JOURNAL OF HEPATOLOGY (2019)
Antiviral Activity, Safety, and Pharmacokinetics of Capsid Assembly Modulator NVR 3-778 in Patients with Chronic HBV Infection
Man Fung Yuen et al.
GASTROENTEROLOGY (2019)
Novel developments of hepatitis B: treatment goals, agents and monitoring tools
Lung-Yi Mak et al.
EXPERT REVIEW OF CLINICAL PHARMACOLOGY (2019)
Hepatitis B Virus Serum DNA and RNA Levels in Nucleos(t)ide Analog-Treated or Untreated Patients During Chronic and Acute Infection
Emily K. Butler et al.
HEPATOLOGY (2018)
Relationship between serum HBV-RNA levels and intrahepatic viral as well as histologic activity markers in entecavir-treated patients
Jing Wang et al.
JOURNAL OF HEPATOLOGY (2018)
Review article: hepatitis B core-related antigen (HBcrAg): an emerging marker for chronic hepatitis B virus infection
L. -Y. Mak et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2018)
Reduction of covalently closed circular DNA with long-term nucleos(t)ide analogue treatment in chronic hepatitis B
Ching-Lung Lai et al.
JOURNAL OF HEPATOLOGY (2017)
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
JOURNAL OF HEPATOLOGY (2017)
Relationship between HBsAg, HBcrAg and hepatocellular carcinoma in patients with undetectable HBV DNA under nucleos(t)ide therapy
K. -S. Cheung et al.
JOURNAL OF VIRAL HEPATITIS (2017)
Hepatitis B virus core-related antigen as a surrogate marker for covalently closed circular DNA
Danny Ka-Ho Wong et al.
LIVER INTERNATIONAL (2017)
Association of Hepatitis B Core-Related Antigen With Hepatitis B Virus Reactivation in Occult Viral Carriers Undergoing High-Risk Immunosuppressive Therapy
Wai-Kay Seto et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2016)
Serum hepatitis B virus RNA is encapsidated pregenome RNA that may be associated with persistence of viral infection and rebound
Jie Wang et al.
JOURNAL OF HEPATOLOGY (2016)
Linearized hepatitis B surface antigen and hepatitis B core-related antigen in the natural history of chronic hepatitis B
W. -K. Seto et al.
CLINICAL MICROBIOLOGY AND INFECTION (2014)
Serum HBV RNA and HBeAg are useful markers for the safe discontinuation of nucleotide analogue treatments in chronic hepatitis B patients
Masataka Tsuge et al.
JOURNAL OF GASTROENTEROLOGY (2013)
Correlation Between Serum Hepatitis B Virus Core-Related Antigen and Intrahepatic Covalently Closed Circular DNA in Chronic Hepatitis B Patients
Fumitaka Suzuki et al.
JOURNAL OF MEDICAL VIROLOGY (2009)
Hepatitis B virus core-related antigens as markers for monitoring chronic hepatitis B infection
Danny Ka-Ho Wong et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2007)
Share Paper
